PerkinElmer (United States): stocks, financial statements

Disable ads for free
Dividends News
Favorites

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

  • PKI Ticker
  • NYSE Exchange
  • 12,500 Employees
2 rated
  • $127.50, +$0.43 (+0.34%) Previous Close
  • 1,268,165 Previous Volume
  • $62.91 / $142.65 52 week low / high
  • -10.92% Percent off 52 week high
  • 2020-11-25 Updated
  • 0.22% Dividend Yield (trailing)
  • 0.22% Dividend Yield (forward)
  • 111,017,966 Public float
  • 111,974,000 Outstanding shares
  • 34.48 P/E
  • 14.23 B Market Cap
Disable ads for free

Financial statements — PerkinElmer (United States)

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
19 ← 15 2019 2018 2017 2016 2015
Total Revenue
2.9B 2.8B 2.3B 2.1B 2.3B
Cost Of Revenue
1.6B 1.5B 1.2B 1.1B 1.3B
Gross Profit
1.3B 1.3B 1B 970M 990M
Research and Development
190M 190M 140M 120M 120M
Selling General and Admin
710M 690M 560M 540M 590M
Operating Expense
2.5B 2.4B 1.9B 1.8B 2B
Operating Income
390M 370M 330M 310M 280M
Other Income Expense Net
-150M -110M -34M -62M -35M
EBIT
390M 370M 330M 310M 280M
Interest Income
64M 67M 44M 42M 38M
Pretax Income
240M 260M 300M 240M 240M
Income Tax
9.4M 20M 140M 28M 31M
Minority Interest
0 0 0 0 0
Net Income
230M 240M 160M 230M 210M
Net Income Basic
230M 240M 160M 230M 210M
19 ← 15 2019 2018 2017 2016 2015
Current cash
190M 160M 200M 360M 240M
Short term investments
Receivables
730M 630M 550M 430M 440M
Inventory
360M 340M 350M 250M 290M
Other current assets
100M 100M 94M 160M 68M
Current assets
1.4B 1.2B 1.2B 1.2B 1B
Long term investments
2.9M 2.4M 1.7M 1.6M
Property plant equipment
490M 320M 300M 150M 170M
Goodwill
3.1B 3B 3B 2.2B 2.3B
Intangible assets
1.3B 1.2B 1.3B 420M 490M
Other assets
200M 190M 180M 190M 200M
Total assets
6.5B 6B 6.1B 4.3B 4.2B
Accounts payable
240M 220M 220M 170M 150M
Current long term debt
10M 15M 220M 1.2M 1.1M
Other current liabilities
450M 510M 500M 430M 400M
Total current liabilities
760M 770M 950M 600M 560M
Long term debt
2.2B 1.9B 1.8B 1B 1B
Other liabilities
530M 510M 530M 420M 480M
Minority Interest
0 0 0 0 0
Total Liabilities
3.7B 3.4B 3.6B 2.1B 2.1B
Common stock
110M 110M 110M 110M 110M
Retained earning
2.8B 2.6B 2.4B 2.1B 2B
Treasury stock
980K 1K 1.1M 1M 1.1M
Capital surplus
90M 49M 59M 26M 53M
Shareholder equity
2.8B 2.6B 2.5B 2.2B 2.1B
Net tangible assets
-5.5B -5.2B -5.4B -3.3B -3.4B
19 ← 15 2019 2018 2017 2016 2015
Net Income
230M 240M 160M 230M 210M
Depreciation
210M 180M 110M 100M 110M
Changes in receivables
-93M -80M -130M 13M
Changes in inventories
-9.6M -30M -18M 6.8M -29M
Cash change
26M -36M -160M 120M 63M
Cash flow
360M 310M 290M 350M 290M
Capital expenditures
-81M -93M -39M -32M -30M
Investments
-6.4M -7M 43M -17M 59K
Investing activity other
-1.3M
Total investing cash flows
-490M -160M -1.2B -100M -100M
Dividends paid
-31M -31M -31M -31M -32M
Net borrowings
200M -69M 820M 55M -35M
Other financing cash flows
-31M -47M -23M -2.1M 21M
Cash flow financing
150M -180M 780M -120M -110M
Exchange rate effect
-450K -8M 22M -13M -16M
Disable ads for free
Disable ads for free